The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

Precision BioSciences, Inc. (NASDAQ:DTIL) revealed initial results from the first administration of PBGENE-HBV in cohort 1, ...

Precision BioSciences (DTIL) announced initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ...

New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the Prevention and ...

One hundred and fifty-eight of 244 (64.8%) HBeAg-negative patients had normal ALT levels at baseline. Of these 158 subjects, 85 (53.8%) continued to have normal ALT levels during follow-up ...

[21] According to treatment guidelines in the Unites States (National Guideline Clearinghouse, https://www.guideline.gov), patients with HBeAg-negative chronic hepatitis B should be considered for ...

Blood tests are a routine part of your prenatal care. Here's everything you need to know about what you can expect.

Cook County officials and health care providers gathered at a Friday news conference to remind residents to get tested and ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

StockNews.com lowered shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a hold rating to a sell rating in a ...